These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer. Lyons LS; Rao S; Balkan W; Faysal J; Maiorino CA; Burnstein KL Mol Endocrinol; 2008 Mar; 22(3):597-608. PubMed ID: 18079321 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of homocysteine-induced Rac1/NADPH oxidase activation in mesangial cells: role of guanine nucleotide exchange factor Vav2. Yi F; Chen QZ; Jin S; Li PL Cell Physiol Biochem; 2007; 20(6):909-18. PubMed ID: 17982273 [TBL] [Abstract][Full Text] [Related]
10. The many faces of the guanine-nucleotide exchange factor trio. van Rijssel J; van Buul JD Cell Adh Migr; 2012; 6(6):482-7. PubMed ID: 23076143 [TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling. Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970 [TBL] [Abstract][Full Text] [Related]
12. FARP1, ARHGEF39, and TIAM2 are essential receptor tyrosine kinase effectors for Rac1-dependent cell motility in human lung adenocarcinoma. Cooke M; Kreider-Letterman G; Baker MJ; Zhang S; Sullivan NT; Eruslanov E; Abba MC; Goicoechea SM; García-Mata R; Kazanietz MG Cell Rep; 2021 Nov; 37(5):109905. PubMed ID: 34731623 [TBL] [Abstract][Full Text] [Related]
13. The rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells. Citterio C; Menacho-Márquez M; García-Escudero R; Larive RM; Barreiro O; Sánchez-Madrid F; Paramio JM; Bustelo XR Sci Signal; 2012 Oct; 5(244):ra71. PubMed ID: 23033540 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of guanine nucleotide exchange and Rac-mediated signaling revealed by a dominant negative trio mutant. Debreceni B; Gao Y; Guo F; Zhu K; Jia B; Zheng Y J Biol Chem; 2004 Jan; 279(5):3777-86. PubMed ID: 14597635 [TBL] [Abstract][Full Text] [Related]
15. Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity. Lyons LS; Burnstein KL Mol Endocrinol; 2006 May; 20(5):1061-72. PubMed ID: 16384856 [TBL] [Abstract][Full Text] [Related]
16. PREX1 integrates G protein-coupled receptor and phosphoinositide 3-kinase signaling to promote glioblastoma invasion. Gont A; Daneshmand M; Woulfe J; Lavictoire SJ; Lorimer IA Oncotarget; 2017 Jan; 8(5):8559-8573. PubMed ID: 28051998 [TBL] [Abstract][Full Text] [Related]
17. Vav3-rac1 signaling regulates prostate cancer metastasis with elevated Vav3 expression correlating with prostate cancer progression and posttreatment recurrence. Lin KT; Gong J; Li CF; Jang TH; Chen WL; Chen HJ; Wang LH Cancer Res; 2012 Jun; 72(12):3000-9. PubMed ID: 22659453 [TBL] [Abstract][Full Text] [Related]
18. Vav3 is linked to poor prognosis of pancreatic cancers and promotes the motility and invasiveness of pancreatic cancer cells. Tsuboi M; Taniuchi K; Furihata M; Naganuma S; Kimura M; Watanabe R; Shimizu T; Saito M; Dabanaka K; Hanazaki K; Saibara T Pancreatology; 2016; 16(5):905-16. PubMed ID: 27453460 [TBL] [Abstract][Full Text] [Related]